3edz
From Proteopedia
(Difference between revisions)
												
			
			| Line 12: | Line 12: | ||
| ===Crystal structure of catalytic domain of TACE with hydroxamate inhibitor=== | ===Crystal structure of catalytic domain of TACE with hydroxamate inhibitor=== | ||
| + | |||
| + | <!--  | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_18835710}}, adds the Publication Abstract to the page  | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 18835710 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_18835710}} | ||
| ==About this Structure== | ==About this Structure== | ||
| 3EDZ is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EDZ OCA].  | 3EDZ is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EDZ OCA].  | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:18835710</ref><references group="xtra"/> | ||
| [[Category: ADAM 17 endopeptidase]] | [[Category: ADAM 17 endopeptidase]] | ||
| [[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| Line 48: | Line 57: | ||
| [[Category: Zymogen]] | [[Category: Zymogen]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on  | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun  3 08:43:15 2009'' | 
Revision as of 05:43, 3 June 2009
Crystal structure of catalytic domain of TACE with hydroxamate inhibitor
Template:ABSTRACT PUBMED 18835710
About this Structure
3EDZ is a 2 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Mazzola RD Jr, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X. Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket. Bioorg Med Chem Lett. 2008 Nov 1;18(21):5809-14. Epub 2008 Sep 13. PMID:18835710 doi:10.1016/j.bmcl.2008.09.045
Page seeded by OCA on Wed Jun 3 08:43:15 2009
Categories: ADAM 17 endopeptidase | Homo sapiens | Guo, Z. | Kozlowski, J. | Lavey, B. | Lundell, D. | Madison, V. | Mazzola, R D. | McKittrick, B. | Neng-Yang, S. | Niu, X. | Orth, P. | Sinning, L. | Spitler, J. | Sun, J. | Zhou, G. | Zhu, Z. | Alternative splicing | Cleavage on pair of basic residue | Glycoprotein | Hydrolase | Membrane | Metal-binding | Metalloprotease | Notch signaling pathway | Phosphoprotein | Protease | Sh3-binding | Transmembrane | Zinc | Zn-endopeptidase | Zymogen
